GlassScriptPhysician profile
Christopher W Gist
NPI 1881685584
$1,465.64
in general payments reported to CMS, 2019-2025
13 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $155 · 2021: $364 · 2022: $51.99 · 2023: $59.51 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.41 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $581.48 | 2019-2025 | Acupulse 40wg, Lithovue |
| Astellas Pharma US INC | $230.72 | 2019-2021 | |
| Teleflex LLC | $225.63 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $191.80 | 2023-2025 | Bard Brachysource I-125 Implant Seeds In Readylink, Model 200 Theraseed Palladium-103 In Readylink |
| Karl Storz Endoscopy-America | $57.90 | 2021 | |
| Myovant Sciences INC. | $44.02 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Blue Earth Diagnostics | $22.13 | 2021 | |
| Amgen INC. | $18.86 | 2021 | |
| Sun Pharmaceutical Industries INC. | $15.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.79 | 2021 | |
| Pfizer INC. | $14.63 | 2019 | |
| Medtronic, INC. | $13.48 | 2025 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.